These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 23641676)

  • 1. Pharmacogenetic considerations for late life depression therapy.
    Pitychoutis PM; Kokras N; Sanoudou D; Dalla C; Papadopoulou-Daifoti Z
    Expert Opin Drug Metab Toxicol; 2013 Aug; 9(8):989-99. PubMed ID: 23641676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The usefulness of genotyping cytochrome P450 enzymes in the treatment of depression.
    Dubovsky SL
    Expert Opin Drug Metab Toxicol; 2015 Mar; 11(3):369-79. PubMed ID: 25554071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatments for late-life bipolar disorder.
    Aziz R; Lorberg B; Tampi RR
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetics of antidepressant response.
    Keers R; Aitchison KJ
    Expert Rev Neurother; 2011 Jan; 11(1):101-25. PubMed ID: 21158559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenomics in depression and antidepressants.
    Bondy B
    Dialogues Clin Neurosci; 2005; 7(3):223-30. PubMed ID: 16156381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Possibility of a pharmacogenetic approach for prediction and personalized medication in major depressive disorder treatment].
    Kato M
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2010 Apr; 30(2):83-92. PubMed ID: 20491282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical implications of antidepressant pharmacokinetics and pharmacogenetics.
    Cohen LJ; De Vane CL
    Ann Pharmacother; 1996 Dec; 30(12):1471-80. PubMed ID: 8968460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of pharmacogenetics in the treatment of depression and anxiety disorders.
    Schosser A; Kasper S
    Int Clin Psychopharmacol; 2009 Nov; 24(6):277-88. PubMed ID: 19738481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics and personalized medicine in antidepressant treatment.
    Gvozdic K; Brandl EJ; Taylor DL; Müller DJ
    Curr Pharm Des; 2012; 18(36):5853-78. PubMed ID: 22681166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic polymorphisms of cytochrome P450 enzymes and antidepressant metabolism.
    Porcelli S; Fabbri C; Spina E; Serretti A; De Ronchi D
    Expert Opin Drug Metab Toxicol; 2011 Sep; 7(9):1101-15. PubMed ID: 21736534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic considerations for current state-of-the-art antidepressants.
    Wyska E
    Expert Opin Drug Metab Toxicol; 2019 Oct; 15(10):831-847. PubMed ID: 31526279
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacogenomics of antidepressant drugs.
    Horstmann S; Binder EB
    Pharmacol Ther; 2009 Oct; 124(1):57-73. PubMed ID: 19563827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenetic studies in depression: a proposal for methodologic guidelines.
    Serretti A; Kato M; Kennedy JL
    Pharmacogenomics J; 2008 Apr; 8(2):90-100. PubMed ID: 17684474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenetics and the serotonin transporter in late-life depression.
    Gerretsen P; Pollock BG
    Expert Opin Drug Metab Toxicol; 2008 Dec; 4(12):1465-78. PubMed ID: 19040324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress and prospects in pharmacogenetics of antidepressant drugs.
    Fabbri C; Crisafulli C; Calabrò M; Spina E; Serretti A
    Expert Opin Drug Metab Toxicol; 2016 Oct; 12(10):1157-68. PubMed ID: 27310483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenetic Implications for Antidepressant Pharmacotherapy in Late-Life Depression: A Systematic Review of the Literature for Response, Pharmacokinetics and Adverse Drug Reactions.
    Marshe VS; Islam F; Maciukiewicz M; Bousman C; Eyre HA; Lavretsky H; Mulsant BH; Reynolds CF; Lenze EJ; Müller DJ
    Am J Geriatr Psychiatry; 2020 Jun; 28(6):609-629. PubMed ID: 32122803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenetic guidelines and decision support tools for depression treatment: application to late-life.
    Chang DD; Eyreeuro HA; Abbott R; Coudreaut M; Baune BT; Shaman JA; Lavretsky H; Lenze EJ; Merrill DA; Singh AB; Mulsant BH; Reynolds CF; Müller DJ; Bousman C
    Pharmacogenomics; 2018 Nov; 19(16):1269-1284. PubMed ID: 30422065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An update on antidepressant pharmacotherapy in late-life depression.
    Brender R; Mulsant BH; Blumberger DM
    Expert Opin Pharmacother; 2021 Oct; 22(14):1909-1917. PubMed ID: 33910422
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacogenetics of antidepressant drugs: current clinical practice and future directions.
    Narasimhan S; Lohoff FW
    Pharmacogenomics; 2012 Mar; 13(4):441-64. PubMed ID: 22380000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individualized medicine - implementation of pharmacogenetic diagnostics in antidepressant drug treatment of major depressive disorders.
    Kirchheiner J; Bertilsson L; Bruus H; Wolff A; Roots I; Bauer M
    Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S235-43. PubMed ID: 14677085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.